ARCHIVES

Kessler Says FDA Working To Expedite Secondary Approvals

This article is from The Cancer Letter archive.

Vol. 18 No. 05 | January 31, 1992

Download PDF Visit The Full Archive

Related Articles

FDA Advisors Recommend Approval Of Leucovorin, Hexamethylmelamine

June 16, 1989

In Brief: NCI Gets $937 Million For FY 79 As Congress Adjourns; Cancer Act Renewed For Two Years

October 20, 1978

Brigham & Women’s Suspends Controversial Morcellation Study As Apparent “Difference of Opinion” with FDA Comes to Light

November 26, 2014

More Workers Quit Smoking When Health Messages Combined

August 30, 2002

Shubik Warns NCA Members They May Be Prober’s Next Target

May 22, 1981

Clearinghouse Asks Short Term Test Use To Help In Chemical Selection

September 17, 1977